August 5, 2020

The Niche

Knoepfler lab stem cell blog

stem cell law

2 min read

There was a burst of feeling last night in the stem cell community as word began circulating that a federal court had ruled in favor of the FDA defining manipulated stem cell products as drugs. However, not everyone was pleased with the court ruling. The clinics most directly affected by the ruling were understandably upset, but interestingly some long-time stem cell advocates also were worried. They said there are potentially serious downsides to the federal court ruling. What might be the negative repercussions? The …Read More

2 min read

There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court of Justice ruled today that methods involving not just human embryos but also existing human ESC lines, cannot be patented. Remarkably, this ruling impacts all 27 members of the …Read More